Neurocrine Biosciences
NBIX
#1385
Rank
โ‚ฌ12.04 B
Marketcap
118,98ย โ‚ฌ
Share price
-1.18%
Change (1 day)
15.50%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: โ‚ฌ12.04 Billion

As of November 2024 Neurocrine Biosciences has a market cap of โ‚ฌ12.04 Billion. This makes Neurocrine Biosciences the world's 1385th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Neurocrine Biosciences from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚ฌ12.04 B2.87%
2023โ‚ฌ11.71 B9.4%
2022โ‚ฌ10.70 B50.04%
2021โ‚ฌ7.13 B-2.01%
2020โ‚ฌ7.28 B-17.77%
2019โ‚ฌ8.85 B56.22%
2018โ‚ฌ5.66 B-0.96%
2017โ‚ฌ5.72 B79.04%
2016โ‚ฌ3.19 B-28.39%
2015โ‚ฌ4.46 B217.75%
2014โ‚ฌ1.40 B208.35%
2013โ‚ฌ0.45 B21.23%
2012โ‚ฌ0.37 B3.89%
2011โ‚ฌ0.36 B14.73%
2010โ‚ฌ0.31 B277.44%
2009โ‚ฌ83.51 M-5.47%
2008โ‚ฌ88.35 M-25.76%
2007โ‚ฌ0.11 B-60.24%
2006โ‚ฌ0.29 B-84.78%
2005โ‚ฌ1.96 B48.1%
2004โ‚ฌ1.32 B-13.2%
2003โ‚ฌ1.52 B14.22%
2002โ‚ฌ1.33 B-24.04%
2001โ‚ฌ1.76 B98.08%
2000โ‚ฌ0.89 B67.48%
1999โ‚ฌ0.53 B384.57%
1998โ‚ฌ0.10 B-6.56%
1997โ‚ฌ0.11 B-24.18%
1996โ‚ฌ0.15 B

End of Day market cap according to different sources

On Nov 13th, 2024 the market cap of Neurocrine Biosciences was reported to be:

โ‚ฌ12.04 Billion
by Nasdaq info icon info icon
โ‚ฌ12.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ7.98 B-33.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.43 B 19.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ22.05 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ730.58 B 5,964.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ285.37 B 2,268.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ143.54 B 1,091.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.19 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.78 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA